Effect of Sodium Alendronate on the Final Implant Stability.

December 15, 2021 updated by: Hossam Abdallah Mohammed Ghazzaly, Cairo University

Effect of Sodium Alendronate Versus Sticky Bone as Socket Preservation Materials on the Final Implant Stability. A Randomized Clinical Trial

evaluation of the final implant stability after its placement in sockets preserved with two different socket preservation materials

Study Overview

Status

Recruiting

Detailed Description

compare the stability of implant placement using Osstell ISQ "resonance frequency analyzer", and marginal bone resorption and bone density around implant by X-ray analysis in different socket preservation techniques comparing sodium alendronate with the sticky bone graft technique

Study Type

Interventional

Enrollment (Anticipated)

24

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manial
      • Cairo, Manial, Egypt, 11553
        • Recruiting
        • Hossam Abdallah Mohammed Ghazally
        • Contact:
        • Principal Investigator:
          • Nadia Galal Galal, PHD
        • Sub-Investigator:
          • Mohammad Mohammed Omara, PHD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with seeking implant drive prosthesis after socket has been preserved by either technique.
  • Patients with seeking implant drive prosthesis with Salama Class 3 defective sockets.
  • Both genders males and females will be included.

Exclusion Criteria:

  • General contraindications to implant surgery.
  • Patient seeking immediate implant placement.
  • Subjected to irradiation in the head and neck area less than 1 year before implantation.
  • Untreated periodontitis.
  • Poor oral hygiene and motivation.
  • Uncontrolled diabetes.
  • Pregnant or nursing.
  • Substance abuse.
  • Psychiatric problems or unrealistic expectations.
  • Severe bruxism or clenching.
  • Immunosuppressed or immunocompromised.
  • Treated or under treatment with intravenous amino-bisphosphonates.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Unable to open mouth sufficiently to accommodate the surgical tooling.
  • Patients participating in other studies, if the present protocol could not be properly
  • followed. Referred only for implant placement or unable to attend a 5-year follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: implant placement in defective Sockets preserved with alendronic acid sponge

anesthesia according the site of implant placement were administered using mepivacaine HCl (2%) with levonordefrin 1:20 000 (Scandonest 2%; Septodont, Saint- Maur-des-Fossés, France). Injection to control pain and bleeding for hemostasis. Crestal incision with a full thickness mucoperiosteal flap was reflected .A pilot drill will be used to start the osteotomy preparation, then different drilling sizes will be used to attain the final drill size and the planed implant height and width according to Cone Beam CT. Implants were screwed directly into the osteotomy site, primarily the screwing was done mechanically by Fixture Mount Connection attached to the implant carrier.

The created gap sutured passively to allow tension-free interrupted closure using 3-0 coated undyed braided polyglactin 910 suture material.

Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama&salama Class 3 labial wall defect
Other Names:
  • Implant in socket preserved with sodium alenderonate drug
Active Comparator: Implant placement in Defective sockets preserved with sticky bone

anesthesia according the site of implant placement were administered using mepivacaine HCl (2%) with levonordefrin 1:20 000 (Scandonest 2%; Septodont, Saint- Maur-des-Fossés, France). Injection to control pain and bleeding for hemostasis. Crestal incision with a full thickness mucoperiosteal flap was reflected .A pilot drill will be used to start the osteotomy preparation, then different drilling sizes will be used to attain the final drill size and the planed implant height and width according to Cone Beam CT. Implants were screwed directly into the osteotomy site, primarily the screwing was done mechanically by Fixture Mount Connection attached to the implant carrier.

The created gap sutured passively to allow tension-free interrupted closure using 3-0 coated undyed braided polyglactin 910 suture material.

Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama&salama Class 3 labial wall defect
Other Names:
  • Implant in socket preserved with sodium alenderonate drug

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant stability
Time Frame: 3-4 months after Dental implant placement
Calculate the final implant stability of two groups using Osstell "resonance frequency analyzer"
3-4 months after Dental implant placement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
marginal bone
Time Frame: 3-4 months after Dental implant placement
Evaluation of marginal bone resorption around implant in two groups using superimposition x-ray (CBCT) software analysis
3-4 months after Dental implant placement

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone Density
Time Frame: 3-4 months after Dental implant placement
Evaluation of bone density around the placed implants using x-ray (CBCT) software analysis
3-4 months after Dental implant placement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

May 23, 2021

Study Completion (Anticipated)

October 1, 2022

Study Registration Dates

First Submitted

December 7, 2021

First Submitted That Met QC Criteria

December 15, 2021

First Posted (Actual)

December 17, 2021

Study Record Updates

Last Update Posted (Actual)

December 17, 2021

Last Update Submitted That Met QC Criteria

December 15, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • omfs335

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Labial Wall Defect

Clinical Trials on Socket Preservation technique

Subscribe